Daniel Seehofer
Overview
Explore the profile of Daniel Seehofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
272
Citations
3922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Leonhardi J, Schnarkowski B, Mehdorn M, Hohn A, Niebisch S, Plum P, et al.
In Vivo
. 2024 Dec;
39(1):353-359.
PMID: 39740864
Background/aim: The recently published Node-Reporting and Data System (Node-RADS) can aid the characterization of lymph nodes in cross-sectional imaging. This study investigated the Node-RADS system in computed tomography (CT) to...
12.
Ott F, Korner C, Krohn K, Fischer J, Damm G, Seehofer D, et al.
Arch Toxicol
. 2024 Dec;
99(3):1105-1116.
PMID: 39714734
The Hedgehog (Hh) signaling pathway is essential for maintaining homeostasis during embryogenesis and in adult tissues. In the liver, dysregulation of this pathway often leads to liver cancer development. Recent...
13.
Lederer A, Alina Geisler A, Sucher R, Seehofer D, Hau H, Scheuermann U, et al.
Ann Surg Open
. 2024 Dec;
5(4):e528.
PMID: 39711660
Objective: This study explored the novel application of hyperspectral imaging (HSI) for in vivo allograft perfusion assessment during liver transplantation (LT) and its potential value for predicting early allograft dysfunction...
14.
Zimmermann A, Scheffschick A, Hansel R, Borchardt H, Liu J, Ehnert S, et al.
Arch Toxicol
. 2024 Dec;
99(3):1167-1185.
PMID: 39710784
The development of in vitro hepatocyte cell culture systems is crucial for investigating drug-induced liver injury (DILI). One prerequisite for monitoring DILI related immunologic reactions is the extension of primary...
15.
Uttinger K, Niezold A, Weimann L, Plum P, Baum P, Diers J, et al.
Langenbecks Arch Surg
. 2024 Dec;
410(1):4.
PMID: 39665853
Importance: There is conflicting evidence regarding weekday dependent outcome in complex abdominal surgery, including pancreatic resections. Objective: To clarify weekday-dependency of outcome after pancreatic resections in a comprehensive nationwide context....
16.
Schindler A, Fischer J, Beeskow A, Lincke T, Ebel S, Seehofer D, et al.
J Cancer Res Clin Oncol
. 2024 Nov;
150(11):486.
PMID: 39503874
Purpose: In the treatment of hepatocellular carcinoma (HCC) with transarterial radioembolization (TARE), identifying reliable biomarkers for predicting survival outcomes remains a critical challenge. We aimed to address this gap by...
17.
Leonhardi J, Sabanov A, Hohn A, Sucher R, Seehofer D, Mehdorn M, et al.
Cancer Rep (Hoboken)
. 2024 Sep;
7(9):e2132.
PMID: 39307946
Background: Texture analysis derived from computed tomography (CT) may provide clinically relevant imaging biomarkers associated with tumor histopathology. Perihilar cholangiocarcinoma is a malignant disease with an overall poor prognosis. Aims:...
18.
Stockmann M, Lock J, Vondran F, Seehofer D
Eur J Surg Oncol
. 2024 Sep;
50(12):108697.
PMID: 39305809
No abstract available.
19.
de Fallois J, Gunzel A, Daniel C, Stumpf J, Busch M, Pein U, et al.
Am J Transplant
. 2024 Sep;
25(3):516-530.
PMID: 39303796
Predicting future kidney allograft function is challenging. Novel biomarkers, such as urinary Dickkopf-3 (uDKK3), may help guide donor selection and improve allograft outcomes. In this prospective multicenter pilot trial, we...
20.
Berg T, Aehling N, Bruns T, Welker M, Weismuller T, Trebicka J, et al.
Z Gastroenterol
. 2024 Sep;
62(9):1397-1573.
PMID: 39250961
No abstract available.